8月22日工银前沿医疗股票C净值增长0.53%，今年来累计上涨33.72%

Group 1 - The core viewpoint of the news is the performance and holdings of the ICBC Frontier Medical Stock C fund, which has shown significant growth in recent months and years [1][3]. - As of August 22, 2025, the latest net value of ICBC Frontier Medical Stock C is 3.4340 yuan, reflecting a growth of 0.53% [1]. - The fund's performance over the past month has yielded a return of 4.66%, ranking 800 out of 1018 in its category [1]. - Over the last six months, the fund has achieved a return of 28.81%, ranking 124 out of 975 [1]. - Year-to-date, the fund has delivered a return of 33.72%, ranking 238 out of 965 [1]. - The top ten holdings of the fund account for a total of 59.44%, with significant positions in companies such as Heng Rui Pharmaceutical (9.51%) and Kelun Pharmaceutical (9.16%) [1]. Group 2 - The ICBC Frontier Medical Stock C fund was established on November 23, 2020, and as of June 30, 2025, it has a total scale of 1.26 billion yuan [1]. - The fund manager, Zhao Bei, has extensive experience in the healthcare sector, having held various positions since joining ICBC Credit Suisse in 2010 [2]. - Zhao Bei has been managing the ICBC Healthcare Industry Equity Fund since November 18, 2014, and has also managed other funds related to healthcare and technology innovation [2].